IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO
Nexstar Media Foundation Expands “30 Days of Giving” Initiative, Announces First $5,000 Grants
Keysight Accelerates the Future of Automotive Emergency Communications with Hybrid eCall Certification
Innoviva to Participate in Upcoming Investor Conferences
IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO
Freeman Health System Completes Acquisition of Northwest Health, Expands Regional Care
Other Report or Announcement
Dropbox Completes New Senior Secured Revolving Credit Facility; Announces $900M Stock Repurchase Program
Karooooo Ltd. Group CEO Zak Calisto Featured on Water Tower Research Small-Cap Spotlight
Ceased to be an interested party - Migdal Insurance and Finance Holdings Ltd.